A recent study showed that the distant disease-free survival (DDFS) of patients with Ki-67 <14% and PgR <20% were similar to those of patients with Ki-67 <14% and PgR ≥20% in ER+/HER2- tumours, which supports our assumption [12]. The gene discussed is ERBB2; the disease is neoplasm.